Atrial Fibrillation: Inflammation in Disguise?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Scandinavian Journal of Immunology

• Publication date

  2013-08-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/sji.12061PMID 23672430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Usefulness of the mean platelet volume for predicting new-onset atrial fibrillation after isolated coronary artery bypass grafting

  2014cited by this paper
• The relevance of the association between inflammation and atrial fibrillation

  2013cited by this paper
• Herpes simplex virus infection and risk of atrial fibrillation: a nationwide study.

  2013cited by this paper
• CHADS(2) score, statin therapy, and risks of atrial fibrillation.

  2013cited by this paper
• Mean platelet volume in patients with nonvalvular atrial fibrillation

  2013cited by this paper
• Biomarkers in atrial fibrillation: a clinical review.

  2013cited by this paper
• An inhibitor of the protein kinases TBK1/IKKε improves obesity-related metabolic dysfunctions

  2013cited by this paper
• Platelets: bridging hemostasis, inflammation, and immunity

  2013cited by this paper
• Atrial fibrillation occurring early after cardiovascular surgery: impact of the surgical procedure

  2013cited by this paper
• Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.

  2013cited by this paper
• Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation.

  2013cited by this paper
• C-reactive protein and P-wave in hypertensive patients after conversion of atrial fibrillation

  2013cited by this paper
• Molecular circuits in thrombosis and inflammation

  2013cited by this paper
• The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation.

  2013cited by this paper
• The effect of aspirin on mean platelet volume in patients with paroxysmal atrial fibrillation

  2013cited by this paper
• Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?

  2013cited by this paper
• YKL-40 levels and atrial fibrillation in the general population.

  2013cited by this paper
• Does Location of Epicardial Adipose Tissue Correspond to Endocardial High Dominant Frequency or Complex Fractionated Atrial Electrogram Sites During Atrial Fibrillation?

  2012cited by this paper
• Interleukin-6 Promoter Polymorphisms and Susceptibility to Atrial Fibrillation in Elderly Han Chinese Patients with Essential Hypertension

  2012cited by this paper
• 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.

  2012cited by this paper
• Role of inflammation in early atrial fibrillation recurrence.

  2012cited by this paper
• Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.

  2012cited by this paper
• Serum amyloid a and C-reactive protein independently predict the recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function.

  2012cited by this paper
• Toll-like receptors and macrophage activation in atherosclerosis.

  2012cited by this paper
• Linear catheter ablation of the right atrium for rapid atrial pacing-induced sustained atrial fibrillation in dogs.

  2012cited by this paper
• High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial.

  2012cited by this paper
• Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study.

  2012cited by this paper
• Thrombosis as an intravascular effector of innate immunity

  2012cited by this paper
• Effects of Blood Products on Inflammatory Response in Endothelial Cells In Vitro

  2012cited by this paper
• Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study

  2012cited by this paper
• Electrophysiological Correlation and Prognostic Impact of Heat Shock Protein 27 in Atrial Fibrillation

  2012cited by this paper
• Diffuse ventricular fibrosis in atrial fibrillation: noninvasive evaluation and relationships with aging and systolic dysfunction.

  2012cited by this paper
• Thiazolidinediones can prevent new onset atrial fibrillation in patients with non-insulin dependent diabetes.

  2012cited by this paper
• Markers of oxidative stress after ablation of atrial fibrillation are associated with inflammation, delivered radiofrequency energy and early recurrence of atrial fibrillation

  2012cited by this paper
• Activation of peripheral blood CD3(+) T-lymphocytes in patients with atrial fibrillation.

  2012cited by this paper
• Inflammation in atrial fibrillation.

  2012cited by this paper
• Type III procollagen-N-peptide as a predictor of persistent atrial fibrillation recurrence after cardioversion.

  2012cited by this paper
• Evidence for a role of advanced glycation end products in atrial fibrillation.

  2012cited by this paper
• 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association.

  2012cited by this paper
• Adipocytes modulate the electrophysiology of atrial myocytes: implications in obesity-induced atrial fibrillation

  2012cited by this paper
• Impaired cardiac autophagy in patients developing postoperative atrial fibrillation.

  2012cited by this paper
• One‐year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke‐free elderly with atrial fibrillation: evidence from a parallel group randomized trial

  2012cited by this paper
• Relation of left atrial spontaneous echocardiographic contrast in patients with mitral stenosis to inflammatory markers.

  2012cited by this paper
• Inflammatory activation and carbohydrate antigen‐125 levels in subjects with atrial fibrillation

  2012cited by this paper
• Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation.

  2012cited by this paper
• N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.

  2011cited by this paper
• Statin Therapy for the Prevention of Atrial Fibrillation Trial (SToP AF trial)

  2011cited by this paper
• Catheter ablation for atrial fibrillation.

  2011cited by this paper
• Intracardiac expression of markers of endothelial damage/dysfunction, inflammation, thrombosis, and tissue remodeling, and the development of postoperative atrial fibrillation

  2011cited by this paper
• Colchicine Reduces Postoperative Atrial Fibrillation: Results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) Atrial Fibrillation Substudy

  2011cited by this paper
• Chronic Heart Failure

  2011cited by this paper
• Effects of Preoperative Short Term Use of Atorvastatin on Endothelial Progenitor Cells after Coronary Surgery: A Randomized, Controlled Trial

  2011cited by this paper
• Is inflammation linked to thrombogenesis in atrial fibrillation?

  2011cited by this paper
• Substrate modifications precede the development of atrial fibrillation after cardiac surgery: a proteomic study.

  2011cited by this paper
• The impact of blood transfusion on morbidity and mortality after cardiac surgery.

  2011cited by this paper
• Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide Cohort Study.

  2011cited by this paper
• Persisting thrombin activity in elderly patients with atrial fibrillation on oral anticoagulation is decreased by anti-inflammatory therapy with intensive cholesterol-lowering treatment.

  2011cited by this paper
• Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study

  2011cited by this paper
• Predictors of atrial fibrillation occurrence after coronary artery bypass graft surgery

  2011cited by this paper
• Prophylactic corticosteroids for cardiopulmonary bypass in adults.

  2011cited by this paper
• Serum resistin level: as a predictor of atrial fibrillation after coronary artery bypass graft surgery

  2011cited by this paper
• Stroke prediction using mean platelet volume in patients with atrial fibrillation

  2011cited by this paper
• Atrial fibrillation and incidence of dementia

  2011cited by this paper
• Efficacy and Safety of Prescription Omega-3 Fatty Acids for the Prevention of Recurrent Symptomatic Atrial Fibrillation: A Randomized Controlled Trial

  2011cited by this paper
• Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study.

  2011cited by this paper
• Intracardiac and extracardiac markers of inflammation during atrial fibrillation.

  2010cited by this paper
• Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia.

  2010cited by this paper
• Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial.

  2010cited by this paper
• Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial.

  2010cited by this paper
• The role of infection in the development of non-valvular atrial fibrillation: up-regulation of Toll-like receptor 2 expression levels on monocytes.

  2009cited by this paper
• Plasma YKL-40, a new biomarker for atrial fibrillation?

  2009cited by this paper
• Chronic heart failure and the substrate for atrial fibrillation.

  2009cited by this paper
• Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction.

  2008cited by this paper
• YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease

  2008cited by this paper
• Focus Issue: Atrial FibrillationClinical Research: Statins and Atrial FibrillationAntiarrhythmic Effect of Statin Therapy and Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

  2008cited by this paper
• Markers of inflammation before and after curative ablation of atrial flutter.

  2008cited by this paper
• Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study

  2008cited by this paper
• Atrial fibrillation in stroke-free patients is associated with memory impairment and hippocampal atrophy.

  2008cited by this paper
• A canine model of sustained atrial fibrillation induced by rapid atrial pacing and phenylephrine.

  2008cited by this paper
• High-Sensitivity C-Reactive Protein and Soluble CD40 Ligand as Indices of Inflammation and Platelet Activation in 880 Patients With Nonvalvular Atrial Fibrillation: Relationship to Stroke Risk Factors, Stroke Risk Stratification Schema, and Prognosis

  2007cited by this paper
• Interleukin-2 serum levels variations in recent onset atrial fibrillation are related with cardioversion outcome.

  2007cited by this paper
• Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.

  2007cited by this paper
• Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery.

  2007cited by this paper
• A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.

  2006cited by this paper
• Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation.

  2006cited by this paper
• Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

  2006cited by this paper
• Circumferential pulmonary-vein ablation for chronic atrial fibrillation.

  2006cited by this paper
• Red cell transfusion is associated with an increased risk for postoperative atrial fibrillation.

  2006cited by this paper
• Decline in C-reactive protein after successful ablation of long-lasting persistent atrial fibrillation.

  2006cited by this paper
• Statin use is associated with a reduction in atrial fibrillation after noncardiac thoracic surgery independent of C-reactive protein.

  2005cited by this paper
• Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.

  2005cited by this paper
• Oral vitamin C administration reduces early recurrence rates after electrical cardioversion of persistent atrial fibrillation and attenuates associated inflammation.

  2005cited by this paper
• N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.

  2005cited by this paper
• Progression to chronic atrial fibrillation after the initial diagnosis of paroxysmal atrial fibrillation: results from the Canadian Registry of Atrial Fibrillation.

  2005cited by this paper
• Effects of methylprednisolone and a biocompatible copolymer circuit on blood activation during cardiopulmonary bypass.

  2005cited by this paper
• Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion.

  2004cited by this paper
• Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation.

  2004cited by this paper
• Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation.

  2004cited by this paper
• Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation.

  2004cited by this paper
• Alterations in Atrial Electrophysiology and Tissue Structure in a Canine Model of Chronic Atrial Dilatation Due to Mitral Regurgitation

  2003cited by this paper

• Statin Therapy in Post-Operative Atrial Fibrillation: Focus on the Anti-Inflammatory Effects

  2021cites this paper
• mRNA expression disturbance of complement system related genes in acute arterial thrombotic and paroxysmal atrial fibrillation patients.

  2020cites this paper
• The efficacy of anti-inflammatory agents in the prevention of atrial fibrillation recurrences.

  2020cites this paper
• Antithrombotic treatment after atrial fibrillation ablation.

  2020cites this paper
• Investigating recurrent cryptogenic strokes in a young female An Unexpected Journey.

  2020cites this paper
• Anti-inflammatory drugs in the prevention of post-operative atrial fibrillation: a literature review

  2019cites this paper
• Association between Vitamin D Deficiency and Cardiovascular Risk Factors in Elderly

  2018cites this paper
• A Potential Role of Esophageal Cancer Related Gene-4 for Atrial Fibrillation

  2017cites this paper
• Effect of vitamin D deficiency on the development of postoperative atrial fibrillation in coronary artery bypass patients

  2016cites this paper
• Atrial Fibrillation Is Associated With a Worse 90-Day Outcome Than Other Cardioembolic Stroke Subtypes

  2016cites this paper
• High sensitive C-reactive protein and interleukin 6 in atrial fibrillation with rheumatic mitral stenosis from Indian cohort

  2016cites this paper
• Incidence of periodontitis in Japanese patients with cardiovascular diseases: a comparison between abdominal aortic aneurysm and arrhythmia

  2015cites this paper
• The characterisation of risk factors, substrate and management strategies for atrial fibrillation.

  2015cites this paper
• Vitamin D and the Risk of Atrial Fibrillation - The Rotterdam Study

  2015cites this paper
• A vital role for complement in heart disease.

  2014cites this paper
• Hemoglobin-associated Oxidative Stress in the Pericardial Compartment of Post-operative Cardiac Surgery Patients

  2014cites this paper
• Poststroke atrial fibrillation: Cause or consequence?

  2014cites this paper
• Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy

  2013cites this paper
• The ICI2013 Scandinavian Journal of Immunology issue

  2013cites this paper
• Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy

  2013cites this paper